» Articles » PMID: 38265170

Type 1 and Type 2 Diabetes Mortality Burden: Predictions for 2030 Based on Bayesian Age-period-cohort Analysis of China and Global Mortality Burden from 1990 to 2019

Overview
Specialty Endocrinology
Date 2024 Jan 24
PMID 38265170
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: This study assessed diabetes (type 1 and type 2) mortality in China and globally from 1990 to 2019, predicting the next decade's trends.

Materials And Methods: Data came from the Global Burden of Disease (GBD) database. The annual percentage change (AAPC) in age-standardized mortality rates (ASMR) for diabetes (type 1 and type 2) during 1990-2019 was calculated. A Bayesian age-period-cohort (BAPC) model predicted diabetes (type 1 and type 2) mortality from 2020 to 2030.

Results: In China, type 1 diabetes deaths declined from 6,005 to 4,504 cases (AAPC -2.827), while type 2 diabetes deaths rose from 64,084 to 168,388 cases (AAPC -0.763) from 1990 to 2019. Globally, type 1 diabetes deaths increased from 55,417 to 78,236 cases (AAPC 0.223), and type 2 diabetes deaths increased from 606,407 to 1,472,934 cases (AAPC 0.365). Both China and global trends showed declining type 1 diabetes ASMR. However, female type 2 diabetes ASMR in China initially increased and then decreased, while males had a rebound trend. Peak type 1 diabetes deaths were in the 40-44 age group, and type 2 diabetes peaked in those over 70. BAPC predicted declining diabetes (type 1 and type 2) mortality burden in China and globally over the next 10 years.

Conclusions: Type 2 diabetes mortality remained high in China and globally despite decreasing type 1 diabetes mortality over 30 years. Predictions suggest a gradual decrease in diabetes mortality over the next decade, highlighting the need for continued focus on type 2 diabetes prevention and treatment.

Citing Articles

Global, regional, and national burden of HIV and tuberculosis and predictions by Bayesian age-period-cohort analysis: a systematic analysis for the global burden of disease study 2021.

Tian X, Wang C, Hao Z, Chen J, Wu N Front Reprod Health. 2024; 6:1475498.

PMID: 39720120 PMC: 11666487. DOI: 10.3389/frph.2024.1475498.


Benefits of Camel Milk over Cow and Goat Milk for Infant and Adult Health in Fighting Chronic Diseases: A Review.

Almasri R, Bedir A, Ranneh Y, El-Tarabily K, Al Raish S Nutrients. 2024; 16(22).

PMID: 39599634 PMC: 11597306. DOI: 10.3390/nu16223848.


The Role of the Pancreatic Extracellular Matrix as a Tissue Engineering Support for the Bioartificial Pancreas.

Santos da Silva T, da Silva-Junior L, Horvath-Pereira B, Valbao M, Garcia M, Lopes J Biomimetics (Basel). 2024; 9(10).

PMID: 39451804 PMC: 11505355. DOI: 10.3390/biomimetics9100598.


The effect of hydrophilic statins on adiponectin, leptin, visfatin, and vaspin levels in streptozocin-induced diabetic rats.

Kaya H, Demirtas B Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39382680 DOI: 10.1007/s00210-024-03517-6.


Optimized automated detection of diabetic retinopathy severity: integrating improved multithresholding tunicate swarm algorithm and improved hybrid butterfly optimization.

Bhimavarapu U Health Inf Sci Syst. 2024; 12(1):42.

PMID: 39144576 PMC: 11319704. DOI: 10.1007/s13755-024-00301-x.


References
1.
Jia H, Liu L, Huo G, Wang R, Zhou Y, Yang L . A qualitative study of the cognitive behavioral intention of patients with diabetes in rural China who have experienced delayed diagnosis and treatment. BMC Public Health. 2020; 20(1):478. PMC: 7147065. DOI: 10.1186/s12889-020-08636-2. View

2.
Bragg F, Holmes M, Iona A, Guo Y, Du H, Chen Y . Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China. JAMA. 2017; 317(3):280-289. PMC: 6520233. DOI: 10.1001/jama.2016.19720. View

3.
Powers A . Type 1 diabetes mellitus: much progress, many opportunities. J Clin Invest. 2021; 131(8). PMC: 8262558. DOI: 10.1172/JCI142242. View

4.
Nakayama Y, Yamaguchi S, Shinzato Y, Okamoto S, Millman J, Yamashiro K . Retrospective exploratory analyses on gender differences in determinants for incidence and progression of diabetic retinopathy in Japanese patients with type 2 diabetes mellitus. Endocr J. 2021; 68(6):655-669. DOI: 10.1507/endocrj.EJ20-0630. View

5.
Rasooly A, Pan Y, Tang Z, Jiangjiang H, Ellen M, Manor O . Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China. Int J Health Policy Manag. 2022; 11(12):3019-3031. PMC: 10105207. DOI: 10.34172/ijhpm.2022.6372. View